This double-blind randomized controlled trial was done in 2015 on 129 eligible females, who had undergone a CS at Valiasr hospital, Birjand, Iran. Based on the findings reported by Sehhati Shaffaie et al. (2012) (
18), the results of the sample size calculation formula for comparing the two means revealed that 36 participants were needed for each study group. However, in order to improve the rigor of the study and also to compensate a probable attrition of 20%, the size of the necessary sample for each study group was determined to be 43. Eligible females were recruited conveniently and were randomly allocated to a placebo and two experimental groups. In one experimental group, the females were treated with 2.5% grape seed extract ointment (group A) while in the other, 5% ointment was used (group B).
Females were included if they were in the 37th to 42nd week of their pregnancy, had undergone a transverse CS; had an age of 15 to 35, a body mass index (BMI) of 18.5 to 25, a singleton pregnancy, and an Iranian ethnicity; had no history of acute or chronic conditions, drug abuse, active smoking, or disorders affecting wound healing (such as diabetes mellitus, anemia, or renal, hepatic and mental disorders); had no allergy to grape seed extract ointment; had not undergone a previous CS; and had no history of using drugs, which could affect wound healing (like glucocorticoids, anticoagulants, immunosuppressant medications, antibiotics and chemotherapy agents). The exclusion criteria included using the ointment irregularly, developing complications associated with long-term use of the ointment, developing wound infection, and making changes in their antibiotic medications.
The grape species, Vitis vinifera L. from the Vitaceae family, was identified by botanists affiliated to Birjand Unviersity, Birjand, Iran. Then, its seeds were separated and sent to Dineh Iran pharmaceutical company in order to produce 2.5% and 5% ointments. In the company, the seeds were washed, dried and grinded by an electric mill. Then, the seed extract was taken through hydroalcoholic extraction procedure, using 70% alcohol as follows. Primarily, 1050 mL of 70% alcohol was added to 50 g of grape seed powder. Then, it was mixed by using a mixer and kept in an oven for 24 hours at 40 ± 2°C. Thereafter, the mixture was sifted. The residue was then mixed with 450 mL of 70% alcohol, kept in the oven for 24 hours at 40 ± 2°C, and sifted. All extracts were dried at 50°C by using an evaporator. This process was undertaken five times in order to produce 99 g of hydroalcoholic grape seed extract. Finally, 30 g ointment tubes containing either placebo or grape seed ointment were produced and numbered with random numbers from 2 to 130. Numbering was performed by a pharmacist, who had produced the ointments, and thus the researchers were blind to the treatments. One ointment tube plus a teaspoon (with a capacity of 0.9 g of the ointment) was given to each participant. For each topical use of the ointment, the candidates were asked to wash their hands thoroughly and then apply a spoonful of the ointment (1 g) to their CS wounds and sutures two times a day (i.e. each twelve hours) from the second to the fifteenth post-CS days. We made telephone contacts with the participants in order to assess and emphasize ointment use. They were recommended to wear cotton shirts, take a shower after hospital discharge and on every other day, remain physically active, avoid lifting heavy loads and eating flatulent foods, avoid doing any movements, which could cause excessive stretching of the sutures, support their abdomen with their hands when coughing, use emollient foods in order to prevent constipation, and receive dairy products, meat, fruits and vegetables on a daily basis.
A metal ruler, the redness, edema, ecchymosis, discharge, approximation (REEDA) scale, and a questionnaire on the female’s personal and CS-related characteristics were used to gather data. The REEDA is an international scale for assessing CS wound. It is comprised of five items of redness, edema, ecchymosis, discharge and approximation, which are scored from 0 to 3, resulting in a total REEDA score of 0 to 15.
The dressing of the CS wound was removed 48 hours after CS, i.e. at hospital discharge. Wound condition was assessed three times including at dressing removal and before applying ointment (T1) as well as on the sixth (T2) and the fourteenth (T3) post-intervention days. Assessments were performed by the first author, who was blind to the treatments, and by using a metal ruler and the REEDA scale. During wound assessment, patients were asked to lie in the supine position.
Primarily, the number of females in each study group was 43. However, four patients were excluded during the course of the study. Therefore, data analysis was done on data retrieved from 125 females (41 in experimental group A, 42 in experimental group B, and 42 in the placebo group). The data were analyzed via the SPSS (v. 19.0) software and by perfoming analysis of variance (ANOVA), Chi-square, Friedman, Wilcoxon, Kruskal-Wallis, and Mann-Whitney U tests at a significance level of 0.05.
This study was carried out after obtaining approval from the Ethics Committee of Birjand University of Medical Sciences (with the code of IR.BUMS.1393.6) and registration in the Iranian Registry of Clinical trials (with the code of IRCT2014122220393N1).